Primary Care Management of Myocarditis and Pericarditis After mRNA COVID-19 Vaccines

This event will provide GPs with guidance on the identification and management of myocarditis and pericarditis following mRNA vaccination.

Myocarditis (inflammation of cardiac muscle) and/or pericarditis (inflammation of pericardium) following mRNA COVID-19 vaccines is predominantly seen in younger males including adolescents up to 2 weeks following vaccination.

Learning outcomes:

By the end of this session, you will be able to:

• Identification and assessment of myocarditis and pericarditis following mRNA COVID-19 Vaccination
• Understanding management and referral guidelines

SPEAKERS

Dr. Scott Parsons - GP Clinical Editor, HealthPathways Melbourne.

A/Prof. Nigel Crawford - Director SAFEVIC, Chair, ATAGI.

Dr. Bryn Jones - Deputy Director of Cardiology - Royal Children’s Hospital.

GPs in the Eastern Melbourne PHN and North Western Melbourne PHN can access the Myocarditis and Pericarditis After mRNA COVID-19 Vaccines pathway on HealthPathways Melbourne. E-mail the team on info@healthpathwaysmelbourne.org.au to retrieve your automatic login.

Event Flyer